C4 Therapeutics: TD Cowen initiates coverage with a Buy rating and $20 price target.

martes, 2 de diciembre de 2025, 7:32 am ET1 min de lectura
CCCC--

C4 Therapeutics: TD Cowen initiates coverage with a Buy rating and $20 price target.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios